| Samuel Bharksuwan, MD | |
|
9303 Pinecroft Dr, Suite 380, The Woodlands, TX 77380-3181 | |
| (281) 587-1300 | |
| (832) 201-8296 |
| Full Name | Samuel Bharksuwan |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 9303 Pinecroft Dr, The Woodlands, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467404590 | NPI | - | NPPES |
| 0430076-02 | Medicaid | TX | |
| K4636 | Other | TX | TEXAS MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | K4636 (Texas) | Primary |
| Entity Name | Samuel Bharksuwan, M.d.p.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962645903 PECOS PAC ID: 5294719357 Enrollment ID: O20090910000618 |
News Archive
Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer following surgery and initial treatment.
NOXXON Pharma today announced the initiation of a Phase I clinical trial for NOX-H94, the Company's third compound to enter the clinic. NOX-H94 is a Spiegelmer designed to treat anemia of chronic disease by targeting the peptide hormone hepcidin, the key regulator of iron metabolism.
Australia's regenerative medicine company, Mesoblast Limited, today announced significant preclinical trial results showing that the proprietary adult stem cell platform could be an effective treatment for diabetes.
Cegedim Dendrite, the leading provider of CRM software and healthcare data to the bio-pharmaceutical industry, today announces the results of The Cegedim Dendrite Market Access Industry Report 2010; a market research survey conducted in May this year across nearly 200 European executives from marketing, market access, market research and sales departments within bio-pharmaceutical organisations.
ZirMed, Inc. announces the release of a secure, national information exchange for healthcare providers. The innovative solution, called ZirMed Clinical Link harnesses the power of ZirMed's connected network of healthcare providers facilitating secure provider-to-provider communications from any EMR or information management system via ZirMed's software-as-a-service (SaaS) platform.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel Bharksuwan, MD Po Box 8668, Spring, TX 77387-8668 Ph: (281) 587-1300 | Samuel Bharksuwan, MD 9303 Pinecroft Dr, Suite 380, The Woodlands, TX 77380-3181 Ph: (281) 587-1300 |
News Archive
Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer following surgery and initial treatment.
NOXXON Pharma today announced the initiation of a Phase I clinical trial for NOX-H94, the Company's third compound to enter the clinic. NOX-H94 is a Spiegelmer designed to treat anemia of chronic disease by targeting the peptide hormone hepcidin, the key regulator of iron metabolism.
Australia's regenerative medicine company, Mesoblast Limited, today announced significant preclinical trial results showing that the proprietary adult stem cell platform could be an effective treatment for diabetes.
Cegedim Dendrite, the leading provider of CRM software and healthcare data to the bio-pharmaceutical industry, today announces the results of The Cegedim Dendrite Market Access Industry Report 2010; a market research survey conducted in May this year across nearly 200 European executives from marketing, market access, market research and sales departments within bio-pharmaceutical organisations.
ZirMed, Inc. announces the release of a secure, national information exchange for healthcare providers. The innovative solution, called ZirMed Clinical Link harnesses the power of ZirMed's connected network of healthcare providers facilitating secure provider-to-provider communications from any EMR or information management system via ZirMed's software-as-a-service (SaaS) platform.
› Verified 4 days ago
John Wakefield Durst, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1001 Medical Plaza Dr Ste 280, The Woodlands, TX 77380 Phone: 281-363-4450 Fax: 281-292-3462 | |
Natalie L Drake, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 17350 St Lukes Way Ste 350, The Woodlands, TX 77384 Phone: 281-203-5115 Fax: 281-203-5119 | |
Jennifer Honeycutt Breazeale, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 17198 St Lukes Way, Suite 540, The Woodlands, TX 77384 Phone: 713-442-1900 | |
Dr. Jon M Rawson, M.D. PH.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1001 Medical Plaza Dr Ste 280, The Woodlands, TX 77380 Phone: 281-363-4445 Fax: 281-292-4419 | |
Christina Nestlerode, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 17198 St Lukes Way Ste 440, The Woodlands, TX 77384 Phone: 936-266-2500 | |
Latoia Monneque Marks, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 17198 St. Luke's Way, The Woodlands, TX 77384 Phone: 936-266-2500 | |
Dr. Erica Ruth Chapman, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 17198 St Lukes Way Ste 540, The Woodlands, TX 77384 Phone: 713-442-1900 |